Last reviewed · How we verify
NCT06223867: Jaspr-PartA
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
NA trial testing Jaspr App + JAH in Suicidal Ideation in 670 participants. Currently enrolling.
31 March 2028
Quick facts
| Lead sponsor | University of Massachusetts, Worcester |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 670 |
| Start date | 23 February 2024 |
| Primary completion | 31 March 2028 |
| Estimated completion | 31 March 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Jaspr App + JAH
- ETAU
Conditions studied
- Suicidal Ideation — all drugs for Suicidal Ideation →
- Suicide Attempt — all drugs for Suicide Attempt →
- Self Harm — all drugs for Self Harm →
Sponsor
University of Massachusetts, Worcester
Who can join
18 and older, any sex, with Suicidal Ideation or Suicide Attempt. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This Study will comprehensively evaluate a multi-component suicide prevention technology (Jaspr Health) that facilitates delivery of suicided-related evidence-based practices (EBPs) while replacing wasted waiting time with productive time in the Emergency Departments (EDs). The EBPs satisfy several key performance elements for systems adopting Zero Suicide. A Complementary Randomized Controlled Trial and Real-World Study for Efficacy, Effectiveness, and Implementation Study Design (CREID) will be used
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06223867
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Suicidal Ideation
Currently open trials in the same condition.
- NCT07438912 — Mind After Midnight · NA · recruiting
- NCT07238192 — Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD · NA · recruiting
- NCT07217444 — Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation · NA · recruiting
- NCT07259408 — Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior · recruiting
- NCT07305701 — Cohort Study on Medical Students' Mental Health · recruiting
Other University of Massachusetts, Worcester trials
Trials by the same sponsor.
- NCT07431528 — Dementia and Storytelling in Vietnam · NA · not yet recruiting
- NCT07060664 — Study on Outcomes of Proximal Humerus Fractures · NA · not yet recruiting
- NCT07520110 — Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis · Phase 3 · not yet recruiting
- NCT06100809 — Does Fatigue Coaching Improve Functioning and Fatigue in Resident Night Shifts · NA · not yet recruiting
- NCT06246539 — Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06223867 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Worcester
- Last refreshed: 20 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06223867.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing